- Dr. Philip Toleikis to retire as of April 30, 2024- Cost savings from restructuring and strategic transformation anticipated to extend runway- Board rebuild underway LONDON, Ontario; BOSTON, Massachusetts – April 25, 2024 – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatment of chronic diseases, today announced the retirement of Chief ...
[ more ]
